content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: OrbiMed Israel GP Ltd. -->
            <cik>0001569590</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001534248</issuerCik>
        <issuerName>Chemomab Therapeutics Ltd.</issuerName>
        <secFileNumber>001-38807</secFileNumber>
        <issuerAddress>
          <com:street1>Kiryat Atidim</com:street1>
          <com:street2>Building 7</com:street2>
          <com:city>Tel Aviv</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6158002</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>972-77-331-0156</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Israel Partners Limited Partnership</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Owner</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Morgan Stanley</name>
          <address>
            <com:street1>1585 Broadway</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>500000</noOfUnitsSold>
        <aggregateMarketValue>1015000.00</aggregateMarketValue>
        <noOfUnitsOutstanding>18508057</noOfUnitsOutstanding>
        <approxSaleDate>09/12/2024</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>American Depositary Shares</securitiesClassTitle>
        <acquiredDate>03/16/2021</acquiredDate>
        <natureOfAcquisitionTransaction>Merger</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>500000</amountOfSecuritiesAcquired>
        <paymentDate>03/16/2021</paymentDate>
        <natureOfPayment>N/A</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>OrbiMed Israel BioFund GP Limited Partnership is the general partner of OrbiMed Israel Partners Limited Partnership. OrbiMed Israel GP Ltd. is the general partner of OrbiMed Israel BioFund GP Limited Partnership.</remarks>
      <noticeSignature>
        <noticeDate>09/12/2024</noticeDate>
        <signature>/s/ Douglas Coon, CCO, OrbiMed Israel GP Ltd., general partner of the general partner of OrbiMed Israel Partners Limited Partnership</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3235}]
text: 144
  0001569590
  XXXXXXXX
  LIVE
  0001534248
  Chemomab Therapeutics Ltd.
  001-38807
  Kiryat Atidim
  Building 7
  Tel Aviv
  L3
  6158002
  972-77-331-0156
  OrbiMed Israel Partners Limited Partnership
  Owner
  American Depositary Shares
  Morgan Stanley
  1585 Broadway
  New York
  NY
  10036
  500000
  1015000.00
  18508057
  09/12/2024
  Nasdaq Stock Market
  American Depositary Shares
  03/16/2021
  Merger
  Issuer
  N
  500000
  03/16/2021
  N/A
  Y
  OrbiMed Israel BioFund GP Limited Partnership is the general partner of OrbiMed Israel Partners Limited Partnership. OrbiMed Israel GP Ltd. is the general partner of OrbiMed Israel BioFund GP Limited Partnership.
  09/12/2024
  /s/ Douglas Coon, CCO, OrbiMed Israel GP Ltd., general partner of the general partner of OrbiMed Israel Partners Limited Partnership